Inhibition of SIRT1 using EX527 (Figure 1) reduces PD-L1 nuclear translocation, suppresses tumor growth, and enhances the efficacy of anti-PD-L1 immunotherapy [104]. This evidence concerns the gene CD274 and neoplasm.